• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    12 Health Care Stocks Moving In Friday's After-Market Session

    5/17/24 4:31:00 PM ET
    $ACON
    $AHG
    $AKAN
    $CCLD
    Medical Specialities
    Health Care
    Real Estate
    Real Estate
    Get the next $ACON alert in real time by email

    Gainers

    • Akso Health Group (NASDAQ:AHG) shares rose 11.4% to $0.79 during Friday's after-market session. The company's market cap stands at $116.0 million.
    • China SXT Pharmaceuticals (NASDAQ:SXTC) shares increased by 10.43% to $1.27. The company's market cap stands at $1.1 million.
    • CareCloud (NASDAQ:CCLD) stock increased by 10.07% to $2.84. The company's market cap stands at $45.7 million. The company's, Q1 earnings came out 3 days ago.
    • Eledon Pharma (NASDAQ:ELDN) shares moved upwards by 9.63% to $3.31. The company's market cap stands at $125.5 million.
    • OneMedNet (NASDAQ:ONMD) shares increased by 7.52% to $0.5. The market value of their outstanding shares is at $11.9 million.
    • Reshape Lifesciences (NASDAQ:RSLS) shares increased by 7.32% to $0.19. The market value of their outstanding shares is at $4.4 million. The company's, Q1 earnings came out 2 days ago.

    Losers

    • Jaguar Health (NASDAQ:JAGX) shares declined by 36.8% to $0.16 during Friday's after-market session. The market value of their outstanding shares is at $46.9 million. As per the news, the Q1 earnings report came out 3 days ago.
    • Akanda (NASDAQ:AKAN) stock decreased by 29.38% to $0.12. The market value of their outstanding shares is at $3.9 million.
    • Virios Therapeutics (NASDAQ:VIRI) stock declined by 26.31% to $0.26. The company's market cap stands at $5.0 million.
    • Revelation Biosciences (NASDAQ:REVB) stock fell 8.42% to $1.85. The market value of their outstanding shares is at $3.0 million.
    • Lixte Biotechnology (NASDAQ:LIXT) stock declined by 7.09% to $2.23. The company's market cap stands at $5.0 million.
    • Aclarion (NASDAQ:ACON) shares declined by 5.98% to $0.31. The market value of their outstanding shares is at $2.1 million. As per the news, the Q1 earnings report came out 2 days ago. See Also: www.benzinga.com/money/best-healthcare-stocks/

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $ACON alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACON
    $AHG
    $AKAN
    $CCLD

    CompanyDatePrice TargetRatingAnalyst
    Eledon Pharmaceuticals Inc.
    $ELDN
    6/18/2025$9.00Buy
    H.C. Wainwright
    Eledon Pharmaceuticals Inc.
    $ELDN
    1/28/2025$9.00Buy
    Guggenheim
    CareCloud Inc.
    $CCLD
    11/13/2024$5.00 → $3.50Buy → Neutral
    ROTH MKM
    Eledon Pharmaceuticals Inc.
    $ELDN
    5/13/2022$25.00 → $15.00Overweight
    Cantor Fitzgerald
    Revelation Biosciences Inc.
    $REVB
    2/17/2022$12.00Buy
    Roth Capital
    Virios Therapeutics Inc.
    $VIRI
    12/15/2021$12.00Buy
    HC Wainwright & Co.
    Eledon Pharmaceuticals Inc.
    $ELDN
    11/24/2021$35.00 → $25.00Buy
    HC Wainwright & Co.
    ReShape Lifesciences Inc.
    $RSLS
    10/8/2021$8.00Buy
    Maxim Group
    More analyst ratings

    $ACON
    $AHG
    $AKAN
    $CCLD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Aclarion, Inc. Adopts Limited Duration Stockholder Rights Plan

    BROOMFIELD, Colo., March 19, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc. (NASDAQ:ACON, ACONW)) ("Aclarion" or the "Company") today announced that its Board of Directors (the "Board") has unanimously adopted a limited duration stockholder rights plan (the "Rights Plan"). The Rights Plan is effective immediately and expires in one year. The Rights Plan is intended to enable all stockholders to realize the long-term value of their investment in Aclarion. The Rights Plan is also intended to reduce the likelihood that any person or group gains control of the Company without paying all stockholders an appropriate control premium. The Rights Plan will help to ensure the Board has sufficient time to

    3/19/26 9:25:40 AM ET
    $ACON
    Medical Specialities
    Health Care

    Aclarion Publishes CEO Shareholder Letter Highlighting Strategic Progress and 2026 Catalysts

    Pursuing reimbursement coverage from one or more regional insurance providers in the United States as an important step toward broader payer adoption Initial CLARITY trial readout in Q4 2026 Strong Balance Sheet with Cash Runway into 2028 BROOMFIELD, Colo., March 19, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc., ("Aclarion" or the "Company") (NASDAQ:ACON, ACONW)), a commercial-stage healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, announced today the publication of a Shareholder Letter from Chief Executive Officer Brent Ness providing an update on the company's

    3/19/26 6:00:00 AM ET
    $ACON
    Medical Specialities
    Health Care

    OneMedNet and Navidence Announce Strategic Collaboration: Empowering Pharma with Precision Real-World Data Insights

    MINNEAPOLIS, March 18, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (NASDAQ:ONMD) (the "OneMedNet," the "Company," "we," "us" or "our"), a leading provider of regulatory decision-grade, AI-ready Real-World Data (RWD), today announced a strategic collaboration with Navidence to help research organizations transform rapidly expanding healthcare data into clear, actionable real-world evidence. What This Collaboration Means for the Pharma Market Pharmaceutical companies face growing pressure to integrate high-quality RWD for regulatory submissions, post-market surveillance, and AI model training. Navidence's platform enables precise definition of health data needs via Computable Operationa

    3/18/26 8:50:00 AM ET
    $ONMD
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    $ACON
    $AHG
    $AKAN
    $CCLD
    SEC Filings

    View All

    SEC Form 10-K filed by Aclarion Inc.

    10-K - Aclarion, Inc. (0001635077) (Filer)

    3/18/26 4:57:42 PM ET
    $ACON
    Medical Specialities
    Health Care

    SEC Form PRE 14A filed by Jaguar Health Inc.

    PRE 14A - Jaguar Health, Inc. (0001585608) (Filer)

    3/13/26 4:59:50 PM ET
    $JAGX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 10-K filed by CareCloud Inc.

    10-K - CareCloud, Inc. (0001582982) (Filer)

    3/12/26 4:31:22 PM ET
    $CCLD
    Computer Software: Prepackaged Software
    Technology

    $ACON
    $AHG
    $AKAN
    $CCLD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by Akso Health Group

    3 - Akso Health Group (0001702318) (Issuer)

    3/18/26 5:27:12 PM ET
    $AHG
    Real Estate

    SEC Form 3 filed by Akso Health Group

    3 - Akso Health Group (0001702318) (Issuer)

    3/18/26 10:16:26 AM ET
    $AHG
    Real Estate

    SEC Form 3 filed by Akso Health Group

    3 - Akso Health Group (0001702318) (Issuer)

    3/18/26 10:00:57 AM ET
    $AHG
    Real Estate

    $ACON
    $AHG
    $AKAN
    $CCLD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    H.C. Wainwright resumed coverage on Eledon Pharmaceuticals with a new price target

    H.C. Wainwright resumed coverage of Eledon Pharmaceuticals with a rating of Buy and set a new price target of $9.00

    6/18/25 7:57:38 AM ET
    $ELDN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Guggenheim initiated coverage on Eledon Pharmaceuticals with a new price target

    Guggenheim initiated coverage of Eledon Pharmaceuticals with a rating of Buy and set a new price target of $9.00

    1/28/25 7:12:35 AM ET
    $ELDN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    CareCloud downgraded by ROTH MKM with a new price target

    ROTH MKM downgraded CareCloud from Buy to Neutral and set a new price target of $3.50 from $5.00 previously

    11/13/24 7:36:28 AM ET
    $CCLD
    Computer Software: Prepackaged Software
    Technology

    $ACON
    $AHG
    $AKAN
    $CCLD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Hrt Financial Lp bought $40,650 worth of Class A Shares (29,036 units at $1.40) and sold $10,150 worth of Class A Shares (7,868 units at $1.29) (SEC Form 4)

    4 - AKANDA CORP. (0001888014) (Issuer)

    1/20/26 2:07:19 PM ET
    $AKAN
    Medicinal Chemicals and Botanical Products
    Health Care

    Chief Executive Officer Ness Brent bought $62 worth of shares (10 units at $6.20), increasing direct ownership by 1,000% to 11 units (SEC Form 4)

    4 - Aclarion, Inc. (0001635077) (Issuer)

    12/1/25 5:00:02 PM ET
    $ACON
    Medical Specialities
    Health Care

    Chief Medical Officer Yu Jeffrey converted options into 2,307,549 shares, bought $959,586 worth of shares (2,010,479 units at $0.48) and was granted 245,000 shares, increasing direct ownership by 165% to 7,326,223 units (SEC Form 4)

    4 - OneMedNet Corp (0001849380) (Issuer)

    11/26/25 9:56:08 PM ET
    $ONMD
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    $ACON
    $AHG
    $AKAN
    $CCLD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Eledon Pharmaceuticals Inc.

    SC 13G/A - Eledon Pharmaceuticals, Inc. (0001404281) (Subject)

    11/14/24 4:51:31 PM ET
    $ELDN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Aclarion Inc.

    SC 13G/A - Aclarion, Inc. (0001635077) (Subject)

    11/13/24 3:06:29 PM ET
    $ACON
    Medical Specialities
    Health Care

    SEC Form SC 13G filed by OneMedNet Corp

    SC 13G - OneMedNet Corp (0001849380) (Subject)

    11/12/24 3:35:37 PM ET
    $ONMD
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    $ACON
    $AHG
    $AKAN
    $CCLD
    Leadership Updates

    Live Leadership Updates

    View All

    LIXTE Biotechnology Appoints Sidney Braun as CEO of its Liora Technologies Europe Ltd. Subsidiary

    BOCA RATON, Fla., Feb. 18, 2026 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. ("LIXTE" or the "Company") (NASDAQ:LIXT), a clinical stage pharmaceutical and med-tech company focused on advancing cancer treatments, today announced it has appointed Sidney Braun as Chief Executive Officer of the Company's Liora Technologies Europe Ltd. subsidiary ("Liora"). A veteran of the healthcare industry, Braun brings to Liora more than two decades of operational and strategic advisory experience at companies in North America, Europe and Israel. He was instrumental in the creation of Liora and facilitated LIXTE's acquisition of Liora's assets in November 2025 from Orbit Capital, Inc. Over his

    2/18/26 8:00:00 AM ET
    $LIXT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    CareCloud Appoints Chief Strategy Officer to Lead Enterprise AI Platform as Company Enters 2026 as Its Defining AI Year

    Strategic leadership alignment positions CareCloud to scale execution, expand margins, and accelerate AI-driven innovation across ambulatory and hospital markets SOMERSET, N.J., Dec. 29, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ:CCLD, CCLDO)), ("CareCloud" or the "Company") a leader in healthcare technology and AI-powered solutions, today announced leadership promotions designed to align the organization for its next phase of growth and to position 2026 as a defining year for enterprise AI innovation across the Company's platform. Effective January 1, 2026, A. Hadi Chaudhry will serve as Chief Strategy Officer, leading CareCloud's enterprise AI vision, platform innovation, and com

    12/29/25 8:00:00 AM ET
    $CCLD
    Computer Software: Prepackaged Software
    Technology

    Aclarion Appoints Jason Brosniak as Commercial Director to Drive Adoption and Market Expansion in the Eastern U.S.

    Proven commercial leader with 20+ years of experience driving revenue growth and market adoption for early-stage and high-growth MedTech companiesStrong track record of launching breakthrough technologies across spine, neurosurgery and pain managementStrengthens Aclarion's commercial execution as the Company expands adoption and payer engagement across the Eastern U.S. BROOMFIELD, Colo., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., ("Aclarion" or the "Company") (NASDAQ:ACON, ACONW)), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, today announced the

    12/2/25 8:00:00 AM ET
    $ACON
    Medical Specialities
    Health Care

    $ACON
    $AHG
    $AKAN
    $CCLD
    Financials

    Live finance-specific insights

    View All

    Aclarion, Inc. Adopts Limited Duration Stockholder Rights Plan

    BROOMFIELD, Colo., March 19, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc. (NASDAQ:ACON, ACONW)) ("Aclarion" or the "Company") today announced that its Board of Directors (the "Board") has unanimously adopted a limited duration stockholder rights plan (the "Rights Plan"). The Rights Plan is effective immediately and expires in one year. The Rights Plan is intended to enable all stockholders to realize the long-term value of their investment in Aclarion. The Rights Plan is also intended to reduce the likelihood that any person or group gains control of the Company without paying all stockholders an appropriate control premium. The Rights Plan will help to ensure the Board has sufficient time to

    3/19/26 9:25:40 AM ET
    $ACON
    Medical Specialities
    Health Care

    CareCloud Reports Record Net Income and First Full-Year Positive EPS Since IPO, Exceeds Revenue Guidance and Issues 2026 Growth Outlook| Introduces AI Products

     SOMERSET, N.J., March 12, 2026 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ:CCLD, CCLDO)), a leader in healthcare technology and generative AI solutions, today announced financial results for the full year and quarter ended December 31, 2025. The Company exceeded its full-year revenue guidance, delivered its seventh consecutive quarter of positive GAAP net income, and achieved its first full-year positive GAAP EPS since its 2014 IPO — capping a transformative year of growth, profitability, entry into the inpatient software market, AI product launches, disciplined execution and cash flow generation. Financial Highlights Full Year  Fourth Quarter   FY 2025  FY 2024  Change  Q4 2025   Q4 2024

    3/12/26 7:00:00 AM ET
    $CCLD
    Computer Software: Prepackaged Software
    Technology

    CareCloud to Announce Fourth Quarter and Full Year 2025 Results on March 12, 2026

    SOMERSET, N.J., Feb. 19, 2026 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ:CCLD, CCLDO)) ("CareCloud" or the "Company"), a leader in AI-powered healthcare technology and revenue cycle management solutions for medical practices and health systems nationwide, will release its financial results for the fourth quarter and full year ended December 31, 2025 before the market opens on Thursday, March 12, 2026. The Company will follow with a conference call for investors at 8:30 a.m. Eastern Time. The live webcast of the conference call and related presentation slides can be accessed at ir.carecloud.com/events. An audio-only option is available by dialing 201-389-0920 and referencing "CareCloud, I

    2/19/26 8:00:00 AM ET
    $CCLD
    Computer Software: Prepackaged Software
    Technology